Ng Carey has filed 5 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 33000 shares of Immix Biopharma, Inc. ($IMMX) on June 20, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 20, 2025 | Immix Biopharma, Inc. | $IMMX | Ng Carey | Director | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 27,722,108 | 9999.99% | 0.12% |
| Aug. 16, 2024 | Immix Biopharma, Inc. | $IMMX | Ng Carey | Director | P | Common Stock | 10000 | $1.86 | 1,045,221.0000 | 0 | 0.97% | 0.00% |
| June 11, 2024 | Immix Biopharma, Inc. | $IMMX | Ng Carey | Director | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | Immix Biopharma, Inc. | $IMMX | Ng Carey | Director | A | Stock Option (Right to Buy) | 21587 | $0.00 | 21,587.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | Immix Biopharma, Inc. | $IMMX | Ng Carey | Director | A | Stock Option (Right to Buy) | 25512 | $0.00 | 25,512.0000 | 0 | 9999.99% | 0.00% |